These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20207607)

  • 1. Weight gain and insulin resistance in children treated with valproate: the influence of time.
    Masuccio F; Verrotti A; Chiavaroli V; de Giorgis T; Giannini C; Chiarelli F; Mohn A
    J Child Neurol; 2010 Aug; 25(8):941-7. PubMed ID: 20207607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ghrelin in weight gain and growth in epileptic children using valproate.
    Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
    J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate-induced insulin resistance and obesity in children.
    Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F
    Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain in children treated with valproate.
    Sharpe C; Wolfson T; Trauner DA
    J Child Neurol; 2009 Mar; 24(3):338-41. PubMed ID: 19258293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ghrelin really increase in epileptic children treated with valproate?
    Aydin S; Dag E
    J Child Neurol; 2008 Sep; 23(9):1084. PubMed ID: 18827274
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin and visfatin concentrations in children treated with valproic acid.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Ernst B; Hoppichler F; Karall D; Ebenbichler CF; Rostasy K; Luef G
    Epilepsia; 2008 Feb; 49(2):353-7. PubMed ID: 18070089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
    Grosso S; Mostardini R; Piccini B; Balestri P
    Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.
    Verrotti A; D'Egidio C; Mohn A; Coppola G; Chiarelli F
    Obes Rev; 2011 May; 12(5):e32-43. PubMed ID: 20880119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do epileptic children treated with valproate have a risk of excessive weight gain?
    Bosnak M; Dikici B; Haspolat K; Dagli A; Dikici S
    J Child Neurol; 2003 Apr; 18(4):306; author reply 306. PubMed ID: 12760438
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy.
    Kanemura H; Sano F; Maeda Y; Sugita K; Aihara M
    Seizure; 2012 Sep; 21(7):496-500. PubMed ID: 22694920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects?
    Bouhours-Nouet N; Dufresne S; de Casson FB; Mathieu E; Douay O; Gatelais F; Rouleau S; Coutant R
    Diabetes Care; 2008 May; 31(5):1031-6. PubMed ID: 18223033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss.
    Reinehr T; de Sousa G; Roth CL
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):608-12. PubMed ID: 17460495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight change in monozygotic twins treated with valproate.
    Klein KM; Hamer HM; Reis J; Schmidtke J; Oertel WH; Theisen FM; Hebebrand J; Rosenow F
    Obes Res; 2005 Aug; 13(8):1330-4. PubMed ID: 16129714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of abnormal glucose homeostasis and insulin resistance in Turkish obese children and adolescents.
    Atabek ME; Pirgon O; Kurtoglu S
    Diabetes Obes Metab; 2007 May; 9(3):304-10. PubMed ID: 17391156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid.
    Greco R; Latini G; Chiarelli F; Iannetti P; Verrotti A
    Neurology; 2005 Dec; 65(11):1808-9. PubMed ID: 16344528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.